Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Factors associated with being lost to follow-up before completing tuberculosis treatment: analysis of surveillance data.

Millett ER, Noel D, Mangtani P, Abubakar I, Kruijshaar ME.

Epidemiol Infect. 2013 Jun;141(6):1223-31. doi: 10.1017/S095026881200163X. Epub 2012 Jul 30.

PMID:
22846385
2.

[Risk factors associated to tuberculosis patients with positive sputum microscopy].

Godoy P, Nogués A, Alsedà M, Manonelles A, Artigues A, García M.

Gac Sanit. 2001 Nov-Dec;15(6):506-12. Spanish.

3.

Incidence and risk factors for drug intolerance and association with incomplete treatment for tuberculosis: analysis of national case registers for England, Wales and Northern Ireland, 2001-2010.

Smith C, Abubakar I, Thomas HL, Anderson L, Lipman M, Reacher M.

Thorax. 2014 Oct;69(10):956-8. doi: 10.1136/thoraxjnl-2013-204503. Epub 2013 Dec 12.

4.

Factors leading to under-reporting of tuberculosis in the private sector in Korea.

Hong SJ, Park YS, An H, Kang SM, Cho EH, Shin SS.

Int J Tuberc Lung Dis. 2012 Sep;16(9):1221-7. doi: 10.5588/ijtld.11.0782. Epub 2012 Jul 12.

PMID:
22794136
5.

Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon.

Kuaban C, Bame R, Mouangue L, Djella S, Yomgni C.

East Afr Med J. 2009 May;86(5):219-25.

PMID:
20084990
6.

Explaining risk factors for drug-resistant tuberculosis in England and Wales: contribution of primary and secondary drug resistance.

Conaty SJ, Hayward AC, Story A, Glynn JR, Drobniewski FA, Watson JM.

Epidemiol Infect. 2004 Dec;132(6):1099-108.

7.

Delay and completion of tuberculosis treatment: a cross-sectional study in the West Midlands, UK.

Sultan H, Haroon S, Syed N.

J Public Health (Oxf). 2013 Mar;35(1):12-20. doi: 10.1093/pubmed/fds046. Epub 2012 Jun 21.

8.

Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998.

Rose AM, Watson JM, Graham C, Nunn AJ, Drobniewski F, Ormerod LP, Darbyshire JH, Leese J; Public Health Laboratory Service/British Thoracic Society/Department of Health Collaborative Group.

Thorax. 2001 Mar;56(3):173-9. Erratum in: Thorax 2001 Jun;56(6):504.

9.

A five year retrospective surveillance; monitoring and evaluation for the regional tuberculosis control programme in Mersin, Turkey, 2004-2008.

Kurt AO, Saşmaz T, Buğdayci R, Oner S, Yapici G, Ozdemir O.

Cent Eur J Public Health. 2012 Jun;20(2):144-9.

10.

Monitoring tuberculosis treatment outcome: analysis of national surveillance data from a clinical perspective.

Ditah IC, Reacher M, Palmer C, Watson JM, Innes J, Kruijshaar ME, Luma HN, Abubakar I.

Thorax. 2008 May;63(5):440-6. Epub 2007 Jul 5.

PMID:
17615085
11.

Increase in invasive group A streptococcal infections in England, Wales and Northern Ireland, 2008-9.

Lamagni TL, Efstratiou A, Dennis J, Nair P, Kearney J, George R; national incident management team.

Euro Surveill. 2009 Feb 5;14(5). pii: 19110.

12.

Loss to follow-up among adults attending human immunodeficiency virus services in England, Wales, and Northern Ireland.

Rice BD, Delpech VC, Chadborn TR, Elford J.

Sex Transm Dis. 2011 Aug;38(8):685-90. doi: 10.1097/OLQ.0b013e318214b92e.

PMID:
21844719
13.

Risk factors for death during tuberculosis treatment in Orel, Russia.

Dewan PK, Arguin PM, Kiryanova H, Kondroshova NV, Khorosheva TM, Laserson K, Kluge H, Jakubowiak W, Wells C, Kazionny B.

Int J Tuberc Lung Dis. 2004 May;8(5):598-602.

PMID:
15137537
14.

Investigating urban-rural disparities in tuberculosis treatment outcome in England and Wales.

Abubakar I, Crofts JP, Gelb D, Story A, Andrews N, Watson JM.

Epidemiol Infect. 2008 Jan;136(1):122-7. Epub 2007 Mar 15.

15.

Factors associated with deaths among pulmonary tuberculosis patients: a case-control study with secondary data.

Duarte EC, Bierrenbach AL, Barbosa da Silva J Jr, Tauil PL, de Fátima Duarte E.

J Epidemiol Community Health. 2009 Mar;63(3):233-8. doi: 10.1136/jech.2008.078972. Epub 2008 Dec 9.

PMID:
19066188
16.

Tuberculosis treatment outcome monitoring in England, Wales and Northern Ireland for cases reported in 2001.

Antoine D, French CE, Jones J, Watson JM.

J Epidemiol Community Health. 2007 Apr;61(4):302-7.

17.

National enhanced surveillance of meningococcal disease in England, Wales and Northern Ireland, January 1999-June 2001.

Shigematsu M, Davison KL, Charlett A, Crowcroft NS.

Epidemiol Infect. 2002 Dec;129(3):459-70.

18.

Epidemiology of smear-negative pulmonary tuberculosis in the United States, 1993-2008.

Shah NS, Cavanaugh JS, Pratt R, Cain KP, Wells C, Laserson K, Nelson L.

Int J Tuberc Lung Dis. 2012 Sep;16(9):1234-40. doi: 10.5588/ijtld.11.0794. Epub 2012 Jun 28.

PMID:
22748057
19.

Access to HIV community services by vulnerable populations: evidence from an enhanced HIV/AIDS surveillance system.

Madden HC, Phillips-Howard PA, Hargreaves SC, Downing J, Bellis MA, Vivancos R, Morley C, Syed Q, Cook PA.

AIDS Care. 2011 May;23(5):542-9. doi: 10.1080/09540121.2010.525609.

PMID:
21287419
20.
Items per page

Supplemental Content

Write to the Help Desk